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RESULTS: No significant difference has been 
noted. For the intervention group, mean pain score 
for 3 days after discharge was 5.67 (SD 6.89), while 
the control group had a mean of 6.73 (SD 3.99) (p 
= 0.61). As for the number of pills, for the interven-
tion group mean was 8.00 (SD 4.74), while the con-
trol group had a mean of 9.33 (SD 7.05) (p = 0.55).
CONCLUSION: There is no significance in pain 
score and number of narcotic pills when using 
the muscle relaxer cyclobenzaprine as an adjunct 
for pain control following alloplastic breast 
reconstruction.
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INTRODUCTION: In response to a growing opi-
oid crisis, there is an increased focus on reduc-
ing opioid consumption perioperatively. Pectoral 
nerve blocks (Pecs blocks) have previously been 
shown to successfully manage postoperative pain 
in mastectomy patients, decreasing perioperative 
opioid consumption and postoperative nausea. 
Over the past several years, we have begun incor-
porating Pecs blocks into our routine breast sur-
geries including reduction mammoplasty. The 
purpose of this study is to examine the impact 
of Pecs blocks on opioid consumption and anti-
emetic requirement in reduction mammoplasty 
patients.
METHODS: We performed a retrospective review 
of all patients who underwent reduction mammo-
plasty between 2014–2016. All Pecs blocks were 
performed with ropivacaine under ultrasound 
guidance by the anesthesia team after induction 
of general anesthesia, but prior to the start of the 
operation. Demographics, operative details, opi-
oid and antiemetic use, and complications were 
recorded. Opioid consumption was converted to a 
standardized oral morphine equivalence (OME) 
value for comparison. Outcomes of patients who 
received Pecs blocks were compared against those 
who did not.
RESULTS: Seventy patients underwent reduction 
mammoplasty by four different attending plastic 
surgeons at our institution. Twenty-nine patients 
received Pecs blocks in addition to general anesthe-
sia, while 41 patients received only general anesthe-
sia without a Pecs block. These groups were similar 
with respect to age, BMI, average breast tissue resec-
tion, and follow up time. Performing the Pecs 
block added approximately 10 minutes of anesthe-
sia time to the patients’ case. Notably, intraopera-
tive morphine consumption was significantly lower 
(85.03 vs 105.44, p = 0.01) in the Pecs block group. 
Additionally, OME for the first twelve hours follow-
ing surgery remained slightly lower in the pectoral 
group (47.07 vs 49.72, p = 0.76), however did not 
reach significance. PACU antiemetic requirement 
also trended lower in the pectoral block group with 
17.24% of block patients receiving antiemetics vs 
24.39% of patients who did not receive a block (p = 
0.47). This trend continued through the first twelve 
hours following surgery (34.48% vs 43.59%, p = 
0.45). There were no complications related to the 
administration of the Pecs blocks.
CONCLUSION: Pectoral nerve blocks provide a 
safe and effective means of perioperative pain con-
trol in breast reduction mammoplasty patients. 
Administration did not substantially increase 
anesthesia time but did significantly reduce the 
need for intraoperative opioid analgesia.
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INTRODUCTION: Previous research has high-
lighted the gender-based disparities that are pres-
ent throughout the field of surgery.1 The aim of this 
study is to evaluate the breadth and variability of the 
issues facing women in plastic surgery, worldwide.
METHODS: A systematic scoping review was 
undertaken from October 2016 to January 2017, 
with no restrictions on date or language. We fol-
lowed the five scoping review steps as proposed 
by Arskey and O’Malley: (1) Identification of the 
research question; (2) Identification of relevant 
studies; (3) Study selection; (4) Data charting and 
(5) Collation and reporting of results.2 A narrative 
synthesis of the literature according to themed 
issues was developed, together with a summary of 
relevant numeric data.
RESULTS: From the 2,247 articles found in the 
search, a total of 53 articles were included in the 
final analysis. The majority of articles were pub-
lished from the US. Eight themes were identified, 
as follows: 1. Workforce figures; 2. Gender bias 
and discrimination; 3. Leadership and academia; 
4. Mentorship and role models; 5. Pregnancy, par-
enting and childcare; 6. Relationships, work-life 
balance and professional satisfaction; 7. Patient/
public preference; and 10. Retirement and finan-
cial planning.
DISCUSSION AND CONCLUSION: There were 
several key findings. First, despite improvement 
in numbers over time, women plastic surgeons 
continue to be underrepresented in the United 
States, Canada and Europe, with prevalence rang-
ing from 14%-25.7%.3,4 Academic plastic surgeons 
are less frequently female than male, and women 
academic plastic surgeons score less favorably 
when outcomes of academic success, such as h 
index and number of peer-reviewed publications 
are evaluated.5 Finally, there has been a shift 
away from overt discrimination towards a more 
ingrained, implicit bias affecting individuals and 
institutions; most published cases of bias and dis-
crimination are in association with pregnancy.
The first step toward addressing the issues facing 
women plastic surgeons is recognition and articu-
lation of the issues. Further research may focus on 
analyzing geographic variation in the issues and 
developing appropriate interventions.
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INTRODUCTION: In the past decade, women 
have comprised nearly half of U.S. medical school 
graduates. However, women may remain under-
represented among surgical residents and sur-
geons due to factors such as the perceived surgical 
personality, culture, and lifestyle. We conducted 
the current study to assess recent trends of women 
trainees and physicians pursuing careers in plas-
tic and reconstructive surgery to determine dif-
ferences between this field and other surgical 
specialties.
METHODS: We reviewed data published by the 
American Medical Association and the Accredi-
tation Council for Graduate Medical Education 
from 2000 to 2013. We abstracted the number 
of surgeons and surgical residents by sex, race/
ethnicity, and specialty. We compared the ratio of 
female-to-male surgeons and residents as well as 
the racial and ethnic composition of female sur-
geons between specialties to evaluate for potential 
differences
